Nordea Investment Management’s Omega Protein OME Stock Holding History

Nordea Investment Management’s Portfolio OME Stock Details OME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-192,800	Closed	-$3.21M	–	1079
2017 Q3	$3.21M	Buy	192,800 +793	+0.4%	+$12.9K	0.01%	496
2017 Q2	$3.44M	Buy	192,007 +1,700	+0.9%	+$31.8K	0.01%	471
2017 Q1	$3.82M	Buy	190,307 +36,100	+23%	+$841K	0.01%	445
2016 Q4	$3.86M	Buy	154,207 +68,507	+80%	+$1.62M	0.01%	404
2016 Q3	$2M	Buy	85,700 +2,900	+4%	+$68.1K	0.01%	480
2016 Q2	$1.66M	Sell	82,800 -1,100	-1%	-$20.5K	﹤0.01%	456
2016 Q1	$1.42M	Buy	83,900 +3,300	+4%	+$67.6K	﹤0.01%	484
2015 Q4	$1.79M	Buy	80,600 +11,400	+16%	+$237K	0.01%	429
2015 Q3	$1.17M	Buy	69,200 +35,700	+107%	+$556K	﹤0.01%	424
2015 Q2	$461K	Buy	33,500 +1,200	+4%	+$15.9K	﹤0.01%	586
2015 Q1	$442K	Buy	+32,300	New	+$373K	﹤0.01%	597

Nordea Investment Management's OME Position: Q4 2017 in Review

Nordea Investment Management sold out of Omega Protein (OME) in Q4 2017, closing a stake of 192,800 shares — an estimated $3.21M sold.

Nordea Investment Management first reported a position in OME in Q1 2015 and held it in 11 quarters. The position peaked at $3.86M in Q4 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.

Nordea Investment Management reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
Nordea Investment Management sold 192,800 Omega Protein shares in Q4 2017, an estimated $3.21M.
Nordea Investment Management first reported a position in Omega Protein in Q1 2015 and held it in 11 quarters.
Nordea Investment Management's Omega Protein position peaked at $3.86M in Q4 2016.
0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.

Based on Nordea Investment Management's 13F filing for Q4 2017, filed 12 Feb 2018.